<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Two cell specific neutral proteases, tryptase and chymase, are produced by human mast cells (MC) </plain></SENT>
<SENT sid="1" pm="."><plain>Tryptase is constitutively expressed by <z:hpo ids='HP_0000001'>all</z:hpo> MC, whereas chymase is found only in an MC subset </plain></SENT>
<SENT sid="2" pm="."><plain>Very little is known about chymase expression in MC proliferative disorders (<z:hpo ids='HP_0100495'>mastocytosis</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>AIMS AND METHODS: Routinely processed, formalin fixed, and paraffin wax embedded bone marrow trephine biopsy specimens obtained from patients with various subtypes of <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> (n = 47) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; n = 28) were immunostained with antibodies against chymase and tryptase </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath>/reactive bone marrow specimens with intact haemopoiesis (n = 31) served as controls </plain></SENT>
<SENT sid="5" pm="."><plain>The numbers of chymase expressing (C+) and of tryptase expressing (T+) MC were assessed morphometrically using a computer assisted video camera system </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In <z:mpath ids='MPATH_458'>normal</z:mpath>/reactive bone marrow, the numbers of C+ MC (median, 8/mm(2); maximum, 159/mm(2)) were in the same range as those of T+ MC (median, 4/mm(2); maximum, 167/mm(2)) </plain></SENT>
<SENT sid="7" pm="."><plain>Because <z:mpath ids='MPATH_458'>normal</z:mpath> MC express both chymase and tryptase, these findings indicate that the common phenotype of bone marrow MC in <z:mpath ids='MPATH_458'>normal</z:mpath>/reactive states is MC(TC) (MC expressing both tryptase and chymase) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:hpo ids='HP_0100495'>mastocytosis</z:hpo>, the bone marrow exhibited far more T+ MC than C+ MC in almost <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: According to these findings, the predominant MC type in the bone marrow in neoplastic states such as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> is MC(T) (MC expressing only tryptase) </plain></SENT>
<SENT sid="10" pm="."><plain>Although the pathophysiological basis of this apparent lack of chymase expression in most neoplastic MC in <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> and MC involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> remains unknown, this study has produced further evidence of the superior value of antitryptase antibodies in the diagnosis of <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> </plain></SENT>
</text></document>